Fox Chase Cancer Center

Articles

Fox Chase Cancer Center’s Dr. Sameer Patel Named Vice President of the Robert H. Ivy Society of Plastic Surgeons

May 28th 2024

Sameer Patel, MD, FACS, of Fox Chase Cancer Center, was recently named Vice President of the Robert H. Ivy Society of Plastic Surgeons.

Fox Chase Researcher Mitchell Fane Awarded $255,000 Grant to Explore Relationship Between Aging and Melanoma

May 22nd 2024

Mitchell Fane, PhD, has received a grant to investigate the role of aging in immune-regulated reactivation from metastatic melanoma.

Kara Stromberg Receives Keystone Award From Pennsylvania Academy of Nutrition and Dietetics

May 20th 2024

Kara Stromberg, MS, RD, LDN, CDCES, was recognized by the Pennsylvania Academy of Nutrition and Dietetics as a Keystone Award winner.

Fox Chase Researchers Examine Effects of Radiation Therapy Timing on Lifespan of Artificial Urinary Sphincters

May 17th 2024

Fox Chase Cancer Center researchers showed that in men who underwent prostate cancer surgery, urinary sphincter function improved with adjuvant radiation.

Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses

May 8th 2024

Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses

Fox Chase Cancer Center Researchers Show Estrogen Metabolites Contribute to Development of Lung Cancer Among People Who Never Smoked

May 2nd 2024

Fox Chase Cancer Center researchers showed that estrogen is metabolized in lungs, contributing to the development of lung cancer in never smokers.

Fox Chase Cancer Center Welcomes Dr Simon Sung

April 26th 2024

Fox Chase Cancer Center is pleased to announce the hiring of Simon Sung, MD, as an associate professor in the Department of Pathology.

Fox Chase Cancer Center Opens First New Jersey Location in Voorhees

April 18th 2024

Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard in Voorhees, New Jersey.

Fox Chase Cancer Center and Temple University Hospital Recertified Under ASCO’s Quality Oncology Practice Initiative

April 12th 2024

Fox Chase Cancer Center has been recognized by the QOPI Certification Program LLC as successfully completing a 3-year recertification for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care.

European Urology Names Fox Chase Cancer Center’s Dr. Andres F. Correa Reviewer of the Month

April 10th 2024

The journal European Urology has named Fox Chase Cancer Center urologic oncologist Andres F. Correa, MD, its March 2024 Reviewer of the Month.

Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University Surgeons Elected to Education Committee of the Association for Academic Surgery

April 3rd 2024

Anthony Villano, MD, and Joceline Vu, MD, were recently elected members of the Education Committee of the Association for Academic Surgery.

2023 Fox Chase Cancer Center Annual Report: We Advance Together

March 11th 2024

It is often said that one person can make a difference, but it is also evident that when we band together, we can achieve greatness.

Fox Chase Cancer Center Recognized for Outstanding Achievement by ECOG-ACRIN Cancer Research Group

January 18th 2024

Fox Chase Cancer Center was recognized by the ECOG-ACRIN Cancer Research Group for outstanding achievement in accrual, scientific contribution, and more.

Fox Chase Cancer Center’s Zoe Landau Wins Best Professional Poster Award From International Cancer Education Conference

January 7th 2024

Zoe Landau, MPH, Project Manager in the lab of Linda Fleisher, PhD, MPH, was recently recognized with the Best Professional Poster Award at the 2023 International Cancer Education Conference for her work detailing the mychoice digital health tool.

Fox Chase Cancer Center Graduate Student Billy Truong Recognized for Third Year in a Row With American Society of Hematology Abstract Achievement Award

January 3rd 2024

Fox Chase Cancer Center graduate student Billy Truong was awarded the American Society of Hematology Abstract Achievement Award for the third year in a row for his study on targeting substrate interactions of the ERK2 protein that drive myeloproliferative neoplasms.

Fox Chase Cancer Center’s Edna Cukierman Awarded American Cancer Society’s Wilmott Family Professorship in Pancreatic Cancer

November 26th 2023

Edna “Eti” Cukierman, PhD, Co-Director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute and Co-Leader of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was recently awarded the American Cancer Society’s Wilmott Family Professorship in Pancreatic Cancer.

Fox Chase Cancer Center’s Dr. Elizabeth Plimack Named a Fellow of the American Society of Clinical Oncology

November 24th 2023

Elizabeth Plimack, MD, MS, Deputy Director and Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, was recently recognized as a new fellow of the American Society of Clinical Oncology.

Fox Chase Researcher Henkel Valentine Recognized as an IMPACT Fellow by the National Postdoctoral Association

November 10th 2023

Henkel Valentine, PhD, a postdoctoral fellow in the lab of Philip Abbosh, MD, PhD, in the Nuclear Dynamics and Cancer Research Program at Fox Chase Cancer Center, was one of six postdoctoral researchers nationwide recently recognized as an IMPACT Fellow by the National Postdoctoral Association.

Fox Chase Cancer Center’s Dr. Alexander Kutikov to Receive Andrew C. Novick Award at 2023 International Kidney Cancer Symposium

November 10th 2023

Alexander Kutikov, MD, FACS, chair of the Department of Urology and the Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center, will receive the Andrew C. Novick Award from the Kidney Cancer Association.

Fox Chase Cancer Center Researcher Receives Robert A. Winn Diversity in Clinical Trials Career Development Award

November 5th 2023

Rebecca Shulman, MD, assistant professor in the Department of Radiation Oncology at Fox Chase Cancer Center, was recently recognized with the Robert A. Winn Diversity in Clinical Trials Career Development Award.